We are live on ! Find out more
MRTX

Mirati Therapeutics, Inc. Common Stock
MRTX

Delisted

MRTX was delisted on the 22nd of January, 2024.

Back to rankings

58 hedge funds and large institutions have $319M invested in Mirati Therapeutics, Inc. Common Stock in 2015 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 28 increasing their positions, 7 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

350% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 4

300% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 7

113% more capital invested

Capital invested by funds: $150M → $319M (+$169M)

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

32% more funds holding

Funds holding: 44 → 58 (+14)

Holders
58
Holders Change
+14
Holders Change %
+31.82%
% of All Funds
1.55%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
18
Increased
28
Reduced
7
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$26.1M
2
BBA
Baker Bros. Advisors
New York
+$9.97M
3
ACA
Avoro Capital Advisors
New York
+$7.53M
4
TCM
Tang Capital Management
California
+$3.52M
5
BC
Broadfin Capital
New York
+$2.86M

Top Sellers

Rank Fund Capital Flow
1
QF
QVT Financial
New York
-$1.19M
2
Franklin Resources
Franklin Resources
California
-$927K
3
Goldman Sachs
Goldman Sachs
New York
-$506K
4
Morgan Stanley
Morgan Stanley
New York
-$420K
5
JP Morgan Chase
JP Morgan Chase
New York
-$81.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
TCIM
26
TIAA CREF Investment Management
New York
$801K – – –
OPPM
27
Opus Point Partners Management
New York
$733K +$586K +25,000 New
PC
28
PointState Capital
New York
$733K +$586K +25,000 New
BIM
29
BlackRock Investment Management
Delaware
$725K +$98.9K +4,216 +21%
IAM
30
Integre Asset Management
New York
$712K +$35.2K +1,502 +7%
Renaissance Technologies
31
Renaissance Technologies
New York
$701K +$561K +23,900 New
Bank of New York Mellon
32
Bank of New York Mellon
New York
$666K +$49.1K +2,094 +10%
UBS Group
33
UBS Group
Switzerland
$581K +$189K +8,071 +69%
Royal Bank of Canada
34
Royal Bank of Canada
Ontario, Canada
$520K +$9.17K +391 +2%
Morgan Stanley
35
Morgan Stanley
New York
$493K -$420K -17,925 -52%
BI
36
Boulegeris Investments
Georgia
$484K +$127K +5,425 +49%
California State Teachers Retirement System (CalSTRS)
37
California State Teachers Retirement System (CalSTRS)
California
$458K +$56.3K +2,400 +18%
Geode Capital Management
38
Geode Capital Management
Massachusetts
$349K +$280K +11,927 New
TA
39
Teachers Advisors
New York
$335K +$27.7K +1,181 +12%
SIM
40
Spark Investment Management
New York
$327K +$263K +11,200 New
Charles Schwab
41
Charles Schwab
California
$308K – – –
LCM
42
Logan Capital Management
Pennsylvania
$261K +$209K +8,900 New
MLICM
43
Metropolitan Life Insurance Company (MetLife)
New York
$215K +$172K +7,338 New
NFA
44
Nationwide Fund Advisors
Ohio
$160K +$1.71K +73 +1%
FANJ
45
Financial Architects (New Jersey)
New Jersey
$147K +$46.9K +2,000 +67%
AIG
46
American International Group
New York
$132K – – –
BA
47
BlackRock Advisors
Delaware
$121K +$33.6K +1,434 +53%
Wells Fargo
48
Wells Fargo
California
$69K +$31.1K +1,327 +131%
AllianceBernstein
49
AllianceBernstein
Tennessee
$44K +$25.8K +1,100 +275%
Citigroup
50
Citigroup
New York
$13K -$17.9K -761 -62%
1
2
3

MRTX Hedge Fund Activity: Q1 2015 in Review

58 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Mirati Therapeutics, Inc. Common Stock (MRTX) for Q1 2015, worth a combined $319M — up 113% from $150M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new MRTX positions and 4 closed out — a net gain of 14 holders — while 28 added to existing stakes and 7 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $26.1M. The largest seller was QVT Financial, cutting an estimated $1.19M.

  • 58 institutional investors held Mirati Therapeutics, Inc. Common Stock (MRTX) as of Q1 2015, up from 44 in Q4 2014.
  • Funds reported $319M of Mirati Therapeutics, Inc. Common Stock stock for Q1 2015, up 113% quarter-over-quarter.
  • 18 funds opened new Mirati Therapeutics, Inc. Common Stock positions in Q1 2015 and 4 closed out, a net change of +14 holders.
  • The largest Mirati Therapeutics, Inc. Common Stock buyer in Q1 2015 was Fidelity Investments, an estimated $26.1M added.
  • The largest Mirati Therapeutics, Inc. Common Stock seller in Q1 2015 was QVT Financial, an estimated $1.19M sold.

Based on aggregated 13F filings for Q1 2015.